Typical antipsychotic drugs (e.g. chlorpromazine) have been around since the 1950s. They work by acting as antagonists in the dopaminesystem and aim to reduce the action of dopamine - they are strongly associated with the dopamine hypothesis
Typical antipsychotics - they block dopamine receptors in the synapses
dopamine antagonists work by blocking dopamine receptors in the synapses in the brain, reducing the action of dopamine
initially, dopamine levels buildup after taking chlorpromazine, but then production is reduced
this normalisesneurotransmission in key areas of the brain, which in turn reduces symptoms like hallucinations
Typical antipsychotics - chlorpromazine also has a sedationeffect
chlorpromazine also has an effect on histaminereceptors which appears to lead to a sedation effect
its also used generally to calmanxioushospital patients when they are first admitted to hospital
Atypical antipsychotics - newerdrugs
The aim of developing newer antipsychotics was to maintain or improve upon the effectiveness of drugs in suppressing the symptoms of psychosis and also to minimise the side effects of the drugs used
atypical antipsychotics - clozapine
clozapine binds to dopamine receptors as chlorpromazine does but alsoacts on serotonin and glutamate receptors
this dug was more effective than typical antipsychotics - clozapine reduces depression and anxiety as well as improvingcognitivefunctioning
It also improved mood which is important as it to 50% of people with schizophrenia attempt suicide
Atypical antipsychotics - risperidone
risperideon was developed in The 1990s because clozapine was involved in the deaths of some people from a bloodcondition called agranulocytosis
risperidone like clozapine binds to dopamine and serotonin receptors
but risperidone binds more strongly to dopamine receptors and is therefore moreeffective in smallerdoses than most antipsychotics and has fewersideeffects
one strength of antipsychotics is evidence for their effectiveness
Thornley (2003) reviewed data from 13 trials (1121 participants) and found that chlorpromazine was associated with better functioning and reducedsymptom severity compared with a placebo. There is also support for the benefits of atypical antipsychotics. Meltzer (2012) concluded that clozapine is moreeffective than typicalantipsychotics, and that it’s effective in 30-50% of treatmentresistant cases. This means that, as far as we can tell, antipsychoticswork
one strength of antipsychotics is evidence for their effectiveness: counterpoint
however, most studies are of shorttermeffectsonly and some data sets have been publishedseveral times, exaggerating the size of the evidence base (Healy 2012). also benefits may be due to calmingeffects of drugs rather than realeffects on symptoms. this means the evidence of effectiveness is lessimpressive than it seems.
one limitation of antipsychotic drugs is the likelihood of side effects
typicalantipsychotics are associated with dizziness, weight gain, sleepiness, agitation etc. long term use can lead to lip smacking and grimacing due to dopaminesupersensitivity. the most serious side effect is neurolepticmalignantsyndrome (NMS) caused by blockingdopamine action in the hypothalamus (can be fatal due to disrupted regulation of several body systems). this means that antipsychotics can do harm as well as good and individualsmayavoidthem (reducing effectiveness).
another limitation of antipsychotics is that wedonotknowwhytheywork
the use of most of these drugs is strongly tied up with the dopaminehypothesis and the idea that there are higher than usual levels of dopamine in the subcortex of people with schizophrenia. but there is evidence that this may not be correct and that dopaminelevels in otherparts of the brain are toolow rather than toohigh. if so, most antipsychoticsshouldn’t work. this means that antipsychotics may not be the besttreatment to opt for - perhaps some otherfactor is involved in their apparent success.